Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Germany licenses Oralair for children's grass allergies

This article was originally published in Scrip

Executive Summary

Germany's Paul-Ehrlich Institute has granted a paediatric marketing authorisation for Stallergenes' Oralair Grasses sublingual tablet therapy for desensitisation to grass pollens in children five to 17 years old. It was licensed for adult use in Germany in June last year, and Germany is acting as the reference member state in the EU's mutual recognition procedure for both the adult and child indications.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC031353

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel